High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastomaKenny Yu, Brian Bigger, Roderick S. P. Benson et al.|PLoS ONE|2018Cited by 17
EXTH-57. HIGH CONTENT SCREENING OF PATIENT-DERIVED CELL LINES HIGHLIGHTS THE POTENTIAL OF NON-STANDARD CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF RECURRENT GLIOBLASTOMAJessica Taylor, Brian Bigger, Kenny Yu et al.|Neuro-Oncology|2017Cited by 0
High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of recurrent glioblastomaJessica Taylor, Brian Bigger, Kenny Yu et al.|Neuro-Oncology|2018Cited by 0